Brief: EQL Pharma Q2 Net Sales At SEK 157.2 Mln
BRIEF-EQL Pharma Q2 Net Sales At SEK 157.2 Mln Nov 5 (Reuters) - EQL Pharma AB EQL.ST:
Q2 NET SALES AMOUNT TO SEK 157.2 MILLION, GROWTH OF 82%
Q2 EBITDA MARGIN RECOVERS TO 19%
SALES FORECAST FOR FULL YEAR 2026/27 IS GROWTH OF AROUND 15%
WE EXPECT FOUR ADDITIONAL LAUNCHES DURING FINANCIAL YEAR, BUT FORECAST IS UNCERTAIN
Source text: ID:nWkr6WNc64
Further company coverage: EQL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))